Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CK-636 (CK-0944636)是一种具有细胞渗透性的Arp2/3复合体抑制剂,能抑制肌动蛋白的聚合,对人,裂殖酵母和牛的IC50值分别为4、24 和 32 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 313 | 现货 | ||
10 mg | ¥ 497 | 现货 | ||
25 mg | ¥ 872 | 现货 | ||
50 mg | ¥ 1,390 | 现货 | ||
100 mg | ¥ 2,080 | 现货 | ||
500 mg | ¥ 4,930 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 345 | 现货 |
产品描述 | CK-636 (CK-0944636), an Arp2/3 complex inhibitor, can inhibit actin polymerization induced by the human (IC50: 4 μM), fission yeast (IC50: 24 μM) and bovine (IC50: 32 μM) Arp2/3 complex, respectively. |
靶点活性 | Arp2/3 complex (bovine):32 μM, Arp2/3 complex (fission yeast):24 μM, Arp2/3 complex (human):4 μM |
体内活性 | 通过抑制迁移T细胞前缘板状伪足的形成,CK-636可减慢迁移速度。在活细胞中,CK-636对Arp2/3复合体介导的肌动蛋白聚合有抑制作用,在感染的SKOV3细胞中,CK-63可使肌动蛋白丝的形成减少。此外,CK-636处理的大部分T细胞在通过字型测试实验时会出现一个转角,然后陷入Z字型的界面上。 |
激酶实验 | HDAC inhibition assays: HDAC inhibition assays are performed by Reaction Biology Corp. using isolated human, recombinant full2length HDAC1 and -6 from a baculovirus expression system in Sf9 cells. An acetylated fluorogenic peptide,RHKKAc, derived from residues 379-382 of p53 is used as substrate. The reaction buffer is made up of 50 mM Tris-HCl pH 8.0, 127 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1 mg/mL BSA, and a final concentration of 1% DMSO. Compounds are delivered in DMSO and delivered to enzyme mixture with preincubation of 5-10 min followed by substrate addition and incubation for 2 h at 30°C. Trichostatin A and developer are added to quench the reaction and generate fluorescence, respectively. Dose-response curves are generated starting at 30 μM compound with three-fold serial dilutions to generate a 10-dose plot. IC50 values are then generated from the resulting plots, and the values expressed are the average of duplicate trials ± standard deviation. |
别名 | CK-0944636, CK 636 |
分子量 | 284.38 |
分子式 | C16H16N2OS |
CAS No. | 442632-72-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 47 mg/mL (165.3 mM)
DMSO: 53 mg/mL (186.4 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 3.5164 mL | 17.5821 mL | 35.1642 mL | 87.9105 mL |
5 mM | 0.7033 mL | 3.5164 mL | 7.0328 mL | 17.5821 mL | |
10 mM | 0.3516 mL | 1.7582 mL | 3.5164 mL | 8.7911 mL | |
20 mM | 0.1758 mL | 0.8791 mL | 1.7582 mL | 4.3955 mL | |
50 mM | 0.0703 mL | 0.3516 mL | 0.7033 mL | 1.7582 mL | |
100 mM | 0.0352 mL | 0.1758 mL | 0.3516 mL | 0.8791 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CK-636 442632-72-6 Cytoskeletal Signaling Microtubule Associated CK 0944636 Inhibitor Actin-related protein 2/3 complex CK636 CK-0944636 CK0944636 Arp2/3 Complex inhibit CK 636 inhibitor